Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma
Glioma is one of the most aggressive and common malignant brain tumors. Due to the presence of the blood-brain barrier (BBB), the effectiveness of therapeutics is greatly affected. In this work, to develop an efficient anti-glioma drug with targeting and which was able to cross the BBB, cell-penetra...
Main Authors: | Xi Wang, Yarong Zhao, Shiyan Dong, Robert J. Lee, Dongsheng Yang, Huan Zhang, Lesheng Teng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/19/3540 |
Similar Items
-
The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain
by: Gitanjali Sharma, et al.
Published: (2016-05-01) -
Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application
by: Jing Xie, et al.
Published: (2020-05-01) -
Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma
by: Yue Zhang, et al.
Published: (2017-01-01) -
Enhanced glioma-targeting and stability of LGICP peptide coupled with stabilized peptide DA7R
by: Mingfei Zhang, et al.
Published: (2018-01-01) -
Enhanced blood–brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles
by: Meng Liang, et al.
Published: (2018-01-01)